Nicotine Replacement Treatment for Pregnant Smokers - 1

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Tobacco Use Disorder

In brief

Smoking during pregnancy is an important modifiable cause of poor pregnancy outcomes. Even with augmented behavioral interventions, smoking cessation rates in pregnancy trials rarely exceed 20%. These low quit rates may be due to inadequate treatment of the physical dependence on nicotine. Indeed, medications, which may help to reduce nicotine withdrawal symptoms, are a first-line treatment for smoking treatment in non-pregnant smokers. However, little information is available on the safety or efficacy of medications to treat pregnant smokers. The purpose of this trial is to evaluate the safety and effectiveness of 2 mg nicotine gum in promoting smoking cessation during pregnancy. The design is a randomized, placebo controlled trial where subjects are randomized to nicotine gum (6 weeks ad libitum use followed by a 6 week taper) or a matching placebo. Women who are doing well at the end of the trial will also be offered gum post-partum for relapse prevention.

Key facts

Study ID

NCT00115687

Run by

National Institute on Drug Abuse (NIDA)

People needed

250

Starts

2002-06-01

Expected to finish

2007-04-01

Last updated by the study team

2017-01-12

Who can join

Age: 16 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patient's gestational age is 26 weeks or less.
• Patient is at least 16 years of age.
• Patient is able to speak English or Spanish.
• Patient intends to carry to term.
• Patient has stable residence.
• Patient has smoked five or more cigarettes everyday for the past seven days.

You may not qualify if…

• Evidence that the patient is pregnant with a fetus with a known congenital abnormality.
• Unstable medical problems (i.e., hyperthyroidism, temporomandibular joint disorder, pre-eclampsia, threatened abortion, hyperemesis gravidarum)
• Multiple Gestation
• Unstable psychiatric disorder
• Current drug or alcohol abuse or dependence

Where it is running

• University of Connecticut Health Center — Farmington, Connecticut, United States
• Hartford Hospital — Hartford, Connecticut, United States
• The Hospital of Central Connecticut — New Britain, Connecticut, United States
• Baystate Medical Center — Springfield, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.